Download PDF
Aktuelle Neurologie 2004; 31(4): 159-169
DOI: 10.1055/s-2003-814929
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Klinik und Therapie der viralen Meningoenzephalitiden

Clinical and Therapeutic Perspectives of Viral MeningoencephalitisU.  Meyding-Lamadé1 , J.  Sellner1 , F.  Martinez-Torres1
  • 1Neurologische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg
Further Information

Publication History

Publication Date:
07 May 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Virale Infektionen des zentralen Nervensystems (ZNS) entwickeln sich meist im Rahmen von Allgemeininfektionen und können sich als Meningitis, Enzephalitis, Myelitis, Radikulomyelitis oder isolierte Hirnnervenläsionen manifestieren. Die virale Meningitis ist die häufigste entzündliche Erkrankung des ZNS und wird wegen ihres blanden Verlaufs oft nicht diagnostiziert. Die virale Meningoenzephalitis kann je nach Erreger und Immunstatus des Patienten schwere, lebensbedrohliche Verläufe und Folgeschäden aufweisen. Die Diagnostik ist durch die modernen bildgebenden, molekularbiologischen und infektiologischen Verfahren zunehmend einfacher geworden. Inzwischen gelingt eine Identifikation des Virus durch Zuhilfenahme hochsensitiver Techniken wie der Polymerasekettenreaktion (PCR) in 50 - 70 % der Fälle und nimmt weiter zu. Teilweise steht eine spezifische antivirale Therapie zur Verfügung, derzeit wird auch eine Reihe von neuen antiviralen Substanzen für die klinische Anwendung getestet. Bei vielen viralen Meningoenzephalitiden stehen jedoch die symptomatische Behandlung und Allgemeinmaßnahmen im Vordergrund. Durch Spontanmutationen, verändertes Reiseverhalten der Bevölkerung und veränderte klimatische Bedingungen können neue Epidemien ausgelöst werden. Kürzlich aufgetretene Enzephalitisepidemien, zum Beispiel durch das Enterovirus Typ 71, das West-Nile-Virus oder das Nipah-Virus, zeigten die potenzielle Gefahr dieser Viren auf.

Abstract

Viral infections of the Central Nervous System (CNS) commonly evolve in the setting of general infection and can cause meningitis, encephalitis, myelitis, radiculomyelitis or cranial nerve palsy, or combinations of these syndroms. Viral meningitis is the most common inflammatory disease of the CNS, the diagnosis is commonly missed because of its relatively benign evolution. Viral meningoencephalitis can be life-threatening and cause severe sequelae, depending on the agent and the immune status of the host. The diagnosis has become less complicated due to modern radiology, infectiology and molecular biology techniques. The causative virus can be identified using highly sensitive methods like the polymerase chain reaction (PCR). Presently, the viral agent can be found in 50 to 70 % cases with PCR, and the sensitivity is increasingly better over time. There are specific therapies for some infectious agents, and new antiviral substances are actually being tested for clinical use. In many cases however, general and symptomatic management remain the standard therapy for viral meningoencephalitis. New epidemics may occur due to spontaneous mutations, travel, and climatic change. The potential danger of viral spread has been highlighted by the recent West-Nile-Virus, Enterovirus Type 71 and Nipah-Virus epidemics.

Literatur

  • 1 Rotbart H A. Viral meningitis.  Semin Neurol. 2000;  3 277-292
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Nowak D A, Boehmer R, Fuchs H H. A retrospective clinical, laboratory and outcome analysis in 43 cases of acute aseptic meningitis.  Eur J Neurol. 2003;  3 271-280
    PubMedGoogle Scholar
  • 3 Connolly K J, Hammer S M. The acute aseptic meningitis syndrome.  Infect Dis Clin North Am. 1990;  4 599-622
    PubMedGoogle Scholar
  • 4 Carpentier A F, Bernard L, Poisson M, Delattre J Y. Central nervous system infections in patients with malignant diseases.  Rev Neurol (Paris). 1996;  10 587-601
    PubMedGoogle Scholar
  • 5 Meyding-Lamadé U. Virale Meningitis. In: Wildemann B, Fogel W, Grau A (Hrsg) Therapieleitfaden Neurologie. Stuttgart; W. Kohlhammer 2003: 194-196
    Google Scholar
  • 6 Meyding-Lamadé U. Chronische lymphozytäre Meningitis. In: Wildemann B, Fogel W, Grau A (Hrsg) Therapieleitfaden Neurologie. Stuttgart; W. Kohlhammer 2003: 196-197
    Google Scholar
  • 7 Bamborschke S, Sandmann J, Wullen T. Mollaret benign recurrent aseptic meningitis. Case report, results of cerebrospinal fluid cytology and review of the literature.  Nervenarzt. 1990;  10 615-619
    PubMedGoogle Scholar
  • 8 Steel J G, Dix R D, Baringer J R. Isolation of herpes simplex virus type I in recurrent (Mollaret) meningitis.  Ann Neurol. 1982;  1 17-21
    PubMedGoogle Scholar
  • 9 Picard F J, Dekaban G A, Silva J, Rice G P. Mollaret's meningitis associated with herpes simplex type 2 infection.  Neurology. 1993;  9 1722-1727
    PubMedGoogle Scholar
  • 10 Kohira I, Ninomiya Y. A case of recurrent aseptic meningitis (Mollaret meningitis) with back pain in which was detected the DNA of herpes simplex virus type 2 in cerebrospinal fluid.  Rinsho Shinkeigaku. 2002;  1 24-26
    PubMedGoogle Scholar
  • 11 Meyding-Lamadé U. Virale Enzephalitis. In: Wildemann B, Fogel W, Grau A (Hrsg) Therapieleitfaden Neurologie. Stuttgart; W. Kohlhammer 2003: 197-205
    Google Scholar
  • 12 Raschilas F, Wolff M, Delatour F. et al . Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study.  Clin Infect Dis. 2002;  3 254-260
    PubMedGoogle Scholar
  • 13 Pfister H-W, Kaiser R. Rationale Differenzialdiagnostik und Vorgehensweise bei Verdacht auf Meningitis/Enzephalitis.  Akt Neurol. 2003;  30 27-34
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system.  Clin Investig. 1992;  1 28-37
    PubMedGoogle Scholar
  • 15 Jacobi C, Reiber H. Quantitation of the specific and polyspecific intrathecal immune response in herpes simplex encephalitis, subacute sclerosing panencephalitis and multiple sclerosis.  Eur J Neurol. 2002;  Suppl 2 132-133
    PubMedGoogle Scholar
  • 16 Harting I, Sellner J, Meyding-Lamadé U, Sartor K. Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis.  Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr. 2003;  5 613-622
    PubMedGoogle Scholar
  • 17 Schwab S, Junger E, Spranger M. et al . Craniectomy: an aggressive treatment approach in severe encephalitis.  Neurology. 1997;  2 412-417
    PubMedGoogle Scholar
  • 18 Whitley R J. Viral encephalitis.  N Engl J Med. 1990;  323 242-250
    CrossrefPubMedGoogle Scholar
  • 19 Meyding-Lamadé U K, Lamadé W R, Wildemann B T. et al . Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery.  Clin Infect Dis. 1999;  1 148-149
    PubMedGoogle Scholar
  • 20 Meyding-Lamadé U K, Oberlinner C, Rau P R. et al . Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.  J Neurovirol. 2003;  1 118-125
    PubMedGoogle Scholar
  • 21 Weber W, Henkes H. Virusinfektionen. In: Sartor K (Hrsg) Neuroradiologie. Vol. 2. Stuttgart; Thieme 2001: 200-204
    Google Scholar
  • 22 Wildemann B, Ehrhart K, Storch-Hagenlocher B. et al . Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis.  Neurology. 1997;  5 1341-1346
    PubMedGoogle Scholar
  • 23 Utley T F, Ogden J A, Gibb A. et al . The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors.  Neuropsychiatry Neuropsychol Behav Neurol. 1997;  3 180-189
    PubMedGoogle Scholar
  • 24 McGrath N, Anderson N E, Croxson M C, Powell K F. Herpes simplex encephalitis treated with acyclovir: diagnosis and long-term outcome.  J Neurol Neurosurg Psychiatry. 1997;  3 321-326
    PubMedGoogle Scholar
  • 25 Gilden D H, Kleinschmidt-DeMasters B K, LaGuardia J J. et al . Neurologic complications of the reactivation of varicella-zoster virus.  N Engl J Med. 2000;  9 635-645
    PubMedGoogle Scholar
  • 26 Corssmit E P, Leverstein-van Hall M A, Portegies P, Bakker P. Severe neurological complications in association with Epstein-Barr virus infection.  J Neurovirol. 1997;  6 460-464
    PubMedGoogle Scholar
  • 27 Wong M, Connolly A M, Noetzel M J. Poliomyelitis-like syndrome associated with Epstein-Barr virus infection.  Pediatr Neurol. 1999;  3 235-237
    PubMedGoogle Scholar
  • 28 Kaiser R. Tick-borne encephalitis (TBE) in Germany and clinical course of the disease.  Int J Med Microbiol. 2002;  291 (Suppl 33) 58-61
    CrossrefPubMedGoogle Scholar
  • 29 Haglund M, Forsgren M, Lindh G, Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy.  Scand J Infect Dis. 1996;  3 217-224
    PubMedGoogle Scholar
  • 30 Wilkerson J A. Rabies update.  Wilderness Environ Med. 2000;  1 31-39
    PubMedGoogle Scholar
  • 31 Dreesen D W, Hanlon C A. Current recommendations for the prophylaxis and treatment of rabies.  Drugs. 1998;  5 801-809
    PubMedGoogle Scholar
  • 32 Frey T K. Neurological aspects of rubella virus infection.  Intervirology. 1997;  2 - 3 167-175
    PubMedGoogle Scholar
  • 33 Spika J S, Wassilak S, Pebody R. et al . Measles and rubella in the World Health Organization European region: diversity creates challenges.  J Infect Dis. 2003;  187 (Suppl 1) S191-S197
    CrossrefPubMedGoogle Scholar
  • 34 Liebert U G. Measles virus infections of the central nervous system.  Intervirology. 1997;  2 - 3 176-184
    PubMedGoogle Scholar
  • 35 Mustafa M M, Weitman S D, Winick N J. et al . Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature.  Clin Infect Dis. 1993;  5 654-660
    PubMedGoogle Scholar
  • 36 Solomon T, Hart C A, Vinjamuri S. et al . Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.  J Child Neurol. 2002;  9 703-705
    PubMedGoogle Scholar
  • 37 Hayes C G. West Nile virus: Uganda, 1937, to New York City, 1999.  Ann N Y Acad Sci. 2001;  951 25-37
    PubMedGoogle Scholar
  • 38 Hubalek Z, Halouzka J. West Nile fever - a reemerging mosquito-borne viral disease in Europe.  Emerg Infect Dis. 1999;  5 643-650
    PubMedGoogle Scholar
  • 39 Lanciotti R S, Roehrig J T, Deubel V. et al . Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.  Science. 1999;  5448 2333-2337
    PubMedGoogle Scholar
  • 40 Leyssen P, Clercq E de, Neyts J. Perspectives for the treatment of infections with Flaviviridae.  Clin Microbiol Rev. 2000;  1 67-82, table of contents
    PubMedGoogle Scholar
  • 41 Lee K E, Umapathi T, Tan C B. et al . The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus.  Ann Neurol. 1999;  3 428-432
    PubMedGoogle Scholar
  • 42 Update: outbreak of Nipah virus - Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep 1999 16: 335-337
    Google Scholar
  • 43 Ahmad K. Malaysia culls pigs as Nipah virus strikes again.  Lancet. 2000;  9225 230
    PubMedGoogle Scholar
  • 44 Goh K J, Tan C T, Chew N K. et al . Clinical features of Nipah virus encephalitis among pig farmers in Malaysia.  N Engl J Med. 2000;  17 1229-1235
    PubMedGoogle Scholar
  • 45 Lim C C, Sitoh Y Y, Hui F. et al . Nipah viral encephalitis or Japanese encephalitis? MR findings in a new zoonotic disease.  AJNR Am J Neuroradiol. 2000;  3 455-461
    PubMedGoogle Scholar
  • 46 Chow V T, Tambyah P A, Yeo W M. et al . Diagnosis of nipah virus encephalitis by electron microscopy of cerebrospinal fluid.  J Clin Virol. 2000;  3 143-147
    PubMedGoogle Scholar
  • 47 Chua K B, Lam S K, Goh K J. et al . The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia.  J Infect. 2001;  1 40-43
    PubMedGoogle Scholar
  • 48 Daniels P, Ksiazek T, Eaton B T. Laboratory diagnosis of Nipah and Hendra virus infections.  Microbes Infect. 2001;  4 289-295
    PubMedGoogle Scholar
  • 49 Chong H T, Kamarulzaman A, Tan C T. et al . Treatment of acute Nipah encephalitis with ribavirin.  Ann Neurol. 2001;  6 810-813
    PubMedGoogle Scholar
  • 50 Cardosa M J, Perera D, Brown B A. et al . Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes.  Emerg Infect Dis. 2003;  4 461-468
    PubMedGoogle Scholar
  • 51 Whitley R J, Gnann J W. Viral encephalitis: familiar infections and emerging pathogens.  Lancet. 2002;  9305 507-513
    PubMedGoogle Scholar
  • 52 Abzug M J, Cloud G, Bradley J. et al . Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.  Pediatr Infect Dis J. 2003;  4 335-341
    PubMedGoogle Scholar
  • 53 Skoldenberg B, Forsgren M, Alestig K. et al . Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.  Lancet. 1984;  8405 707-711
    PubMedGoogle Scholar
  • 54 Whitley R J, Alford C A, Hirsch M S. et al . Vidarabine versus acyclovir therapy in herpes simplex encephalitis.  N Engl J Med. 1986;  3 144-149
    PubMedGoogle Scholar
  • 55 Hacke W, Zeumer H. Computer tomography in herpes simplex encephalitis. Stages in the development of CT changes.  ROFO Fortschr Geb Röntgenstr Nuklearmed. 1981;  4 426-431
    PubMedGoogle Scholar

PD Dr. Uta Meyding-Lamadé

Neurologische Universitätsklinik · Ruprecht-Karls-Universität Heidelberg

Im Neuenheimer Feld 400

69120 Heidelberg

Email: uta_meyding-lamade@med.uni-heidelberg.de

      >